SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-019116
Filing Date
2017-11-13
Accepted
2017-11-13 15:20:56
Documents
52
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q atrn20170930_10q.htm 10-Q 433161
2 EXHIBIT 31.1 ex_99997.htm EX-31.1 14501
3 EXHIBIT 31.2 ex_99998.htm EX-31.2 14139
4 EXHIBIT 32.1 ex_99999.htm EX-32.1 11601
  Complete submission text file 0001437749-17-019116.txt   3536358

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ptix-20170930.xml EX-101.INS 675726
6 XBRL TAXONOMY EXTENSION SCHEMA ptix-20170930.xsd EX-101.SCH 42887
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ptix-20170930_cal.xml EX-101.CAL 24084
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ptix-20170930_def.xml EX-101.DEF 337601
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptix-20170930_lab.xml EX-101.LAB 255143
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptix-20170930_pre.xml EX-101.PRE 344576
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51353 | Film No.: 171195509
SIC: 7389 Services-Business Services, NEC